Want to see VSEE full AI Analyst Report?
VSee Health (VSEE) Ratios
VSee Health Ratios
VSEE's free cash flow for Q2 2026 was $-1.15M. For the 2026 fiscal year, VSEE's free cash flow was increased by $26.75K and operating cash flow was $-1.17M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.51 | 0.16 | 0.16 | 0.29 | 6.62 |
| Quick Ratio | 0.51 | 0.16 | 0.16 | 0.29 | 6.62 |
| Cash Ratio | 0.32 | 0.02 | 0.02 | 0.09 | 4.13 |
| Solvency Ratio | -0.71 | -2.82 | -0.74 | 0.24 | 0.05 |
| Operating Cash Flow Ratio | -0.21 | -0.30 | -0.12 | -0.56 | -3.26 |
| Short-Term Operating Cash Flow Coverage | -1.87 | -0.70 | -1.17 | -2.81 | 0.00 |
| Net Current Asset Value | $ -8.60M | $ -16.99M | $ -4.30M | $ -1.85M | $ -3.34M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.48 | 0.67 | 0.20 | 0.00 |
| Debt-to-Equity Ratio | 0.45 | -516.43 | -0.14 | 1.43 | 0.00 |
| Debt-to-Capital Ratio | 0.31 | 1.00 | -0.16 | 0.59 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 1.03 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.11 | -1081.38 | -0.20 | 7.24 | 1.04 |
| Debt Service Coverage Ratio | -1.99 | -0.20 | -1.33 | 1.08 | 0.00 |
| Interest Coverage Ratio | -3.41 | -293.91 | -0.86 | -13.34 | 0.00 |
| Debt to Market Cap | 0.32 | 0.64 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 20.84 | 0.96 | 0.27 | 0.06 | 0.00 |
| Net Debt to EBITDA | 0.31 | -2.75 | -0.24 | 0.00 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.32% | 68.87% | 66.47% | 75.81% | 80.74% |
| EBIT Margin | -80.94% | -44.94% | -30.99% | -22.95% | 3.44% |
| EBITDA Margin | -62.79% | -32.24% | -30.98% | 0.00% | 0.00% |
| Operating Profit Margin | -65.55% | -596.38% | -32.49% | -26.34% | 3.44% |
| Pretax Profit Margin | -100.18% | -569.46% | -32.73% | -25.40% | 5.27% |
| Net Profit Margin | -100.65% | -553.69% | -65.26% | -13.11% | 6.49% |
| Continuous Operations Profit Margin | -100.65% | -553.69% | -64.61% | -14.52% | 3.79% |
| Net Income Per EBT | 100.47% | 97.23% | 199.42% | 51.61% | 123.18% |
| EBT Per EBIT | 152.82% | 95.49% | 100.71% | 96.43% | 153.14% |
| Return on Assets (ROA) | -65.64% | -288.62% | -466.99% | -32.01% | 0.40% |
| Return on Equity (ROE) | -269.84% | 312105.23% | 94.68% | -231.81% | 0.42% |
| Return on Capital Employed (ROCE) | -155.35% | -6327.92% | 43.58% | 82638.17% | 0.21% |
| Return on Invested Capital (ROIC) | -119.67% | -625.15% | 49.88% | -186.37% | 0.15% |
| Return on Tangible Assets | -168.89% | -1413.99% | -466.99% | -32.01% | 0.40% |
| Earnings Yield | -195.10% | -415.43% | -2.17% | -0.48% | 0.28% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.80 | 4.64 | 9.17 | 16.38 | 25.65 |
| Payables Turnover | 1.31 | 0.76 | 10.33 | 2.24 | 6.98 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 42.26 | 9.83 | 1576.67 | 0.00 | 0.00 |
| Asset Turnover | 0.65 | 0.52 | 7.16 | 2.44 | 0.06 |
| Working Capital Turnover Ratio | -1.22 | -1.03 | -1.87 | -15.53 | 36.78 |
| Cash Conversion Cycle | -214.90 | -403.25 | 4.44 | -140.45 | -38.05 |
| Days of Sales Outstanding | 62.94 | 78.74 | 39.78 | 22.29 | 14.23 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 277.85 | 481.98 | 35.35 | 162.74 | 52.28 |
| Operating Cycle | 62.94 | 78.74 | 39.78 | 22.29 | 14.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -13.68 | -0.57 | -0.06 | -0.15 | -0.06 |
| Free Cash Flow Per Share | -13.80 | -0.57 | -0.06 | -0.15 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | -115.13 | -104.76 | -145.93 | -484337.67 | -200037.67 |
| Capital Expenditure Coverage Ratio | -115.13 | -104.76 | -145.93 | -484337.67 | -200037.67 |
| Operating Cash Flow Coverage Ratio | -1.41 | -0.61 | -1.17 | -2.81 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.24 | -0.56 | -0.11 | -0.23 | -0.08 |
| Free Cash Flow Yield | -46.09% | -42.08% | -0.37% | -0.84% | -0.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.51 | -0.24 | -46.07 | -207.33 | 362.40 |
| Price-to-Sales (P/S) Ratio | 0.52 | 1.33 | 30.07 | 27.18 | 23.50 |
| Price-to-Book (P/B) Ratio | 1.38 | -751.28 | -43.62 | 480.63 | 1.52 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.17 | -2.38 | -272.20 | -119.32 | -287.39 |
| Price-to-Operating Cash Flow Ratio | -2.19 | -2.40 | -274.07 | -119.32 | -287.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.00 | -0.13 | 0.75 | 4.32 |
| Enterprise Value Multiple | -0.51 | -6.88 | -97.30 | 0.00 | 0.00 |
| Enterprise Value | 4.71M | 23.11M | 173.80M | 173.66M | 171.70M |
| EV to EBITDA | -0.51 | -6.88 | -97.30 | 0.00 | 0.00 |
| EV to Sales | 0.32 | 2.22 | 30.14 | 27.23 | 23.40 |
| EV to Free Cash Flow | -1.36 | -3.95 | -272.87 | -119.52 | -286.12 |
| EV to Operating Cash Flow | -1.37 | -3.99 | -274.74 | -119.52 | -286.12 |
| Tangible Book Value Per Share | -32.76 | -1.56 | -0.43 | -0.00 | 11.40 |
| Shareholders’ Equity Per Share | 21.65 | -0.00 | -0.40 | 0.04 | 11.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.03 | -0.97 | 0.43 | 0.28 |
| Revenue Per Share | 58.06 | 1.02 | 0.58 | 0.64 | 0.74 |
| Net Income Per Share | -58.43 | -5.65 | -0.38 | -0.08 | 0.05 |
| Tax Burden | 1.00 | 0.97 | 1.99 | 0.52 | 1.23 |
| Interest Burden | 1.24 | 12.67 | 1.06 | 1.11 | 1.53 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.16 | 1.14 | 0.12 | 0.16 | 0.77 |
| Stock-Based Compensation to Revenue | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.23 | 0.10 | 0.17 | 0.45 | 2.14 |
Currency in USD
